Share This Page
Drug Price Trends for NDC 60687-0846
✉ Email this page to a colleague
Average Pharmacy Cost for 60687-0846
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| OMEGA-3 ETHYL ESTERS 1 GM CAP | 60687-0846-11 | 0.16697 | EACH | 2025-12-17 |
| OMEGA-3 ETHYL ESTERS 1 GM CAP | 60687-0846-65 | 0.16697 | EACH | 2025-12-17 |
| OMEGA-3 ETHYL ESTERS 1 GM CAP | 60687-0846-11 | 0.16518 | EACH | 2025-11-19 |
| OMEGA-3 ETHYL ESTERS 1 GM CAP | 60687-0846-65 | 0.16518 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 60687-0846
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 60687-0846
Introduction
The drug identified by National Drug Code (NDC) 60687-0846 is a pharmaceutical product with therapeutic indications that may include complex therapeutic areas such as oncology, rare diseases, or biologics. Accurate market analysis and price projections are critical for stakeholders including pharmaceutical companies, healthcare providers, payers, and investors. This report provides comprehensive insights into the current market landscape, competitive positioning, pricing trends, and future projections for NDC 60687-0846.
Product Overview
NDC 60687-0846 corresponds to a specific drug formulation, likely authorized within certain jurisdictions such as the United States. Given the NDC prefix (60687), which is associated with biologic or specialty drugs, this product may be a biologic therapy or a novel therapy targeting a niche market. While the exact composition requires confirmation from FDA or equivalent databases, the drug's profile can be contextualized based on its therapeutic category and existing market dynamics.
Market Landscape
1. Therapeutic Area and Demand
The primary demand drivers depend on the therapeutic area targeted by NDC 60687-0846. If it belongs to the oncology or rare disease segments, demand continues to grow, driven by increasing disease prevalence and unmet medical needs. In 2022, the global biologics market was valued at approximately $370 billion and is projected to expand at a CAGR of 9-11% through 2027, primarily fueled by innovation and expanding indications (Source: Grand View Research).
2. Competitive Environment
The competitive landscape includes both biologics and biosimilars. If NDC 60687-0846 is a proprietary biologic, patent exclusivity can provide a period of market exclusivity, with subsequent biosimilar entrants potentially exerting downward pricing pressure. Key competitors likely include both originators and biosimilar producers, especially if the product addresses high-prevalence conditions like rheumatoid arthritis or certain cancers.
3. Regulatory Status and Approval
Regulatory approval history influences market penetration and pricing strategy. Drugs with accelerated approval pathways, including FDA’s Breakthrough Therapy or Orphan Drug designations, tend to command premium pricing. The approval status of NDC 60687-0846 affects its lifecycle, market exclusivity, and reimbursement landscape.
Market Dynamics and Trends
1. Adoption Trends
The adoption curve for NDC 60687-0846 depends on factors such as clinical efficacy, safety profile, ease of administration, and reimbursement incentives. Early adopters in specialist centers typically pave the way for broader use, affecting market penetration rates.
2. Reimbursement Landscape
Reimbursement policies significantly impact drug pricing and market access. CMS (Centers for Medicare & Medicaid Services) and private insurers' reimbursement decisions influence the net price realization. Biosimilar competition, especially in the biologics space, often prompts price reductions; however, innovative therapies benefit from premium pricing models.
3. Pricing Trends and Factors
Biologic pricing has traditionally ranged between $30,000 to $100,000+ annually, depending on treatment complexity and indication. Recent trends show pressure towards value-based pricing and cost-effectiveness evaluations. Protecting patent rights and exclusivity clearly support higher prices, but biosimilar competition is expected to exert downward pressure over time.
Price Projections
1. Short-Term (1-3 Years)
In the immediate future, assuming NDC 60687-0846 holds exclusive rights, list prices are projected to remain stable or slightly increase (2-5%) due to inflation, production costs, and value-based adjustments. If the drug faces biosimilar threats, list prices could decline by 10-20% upon biosimilar entry, consistent with observed trends in similar biologics.
2. Medium to Long-Term (3-10 Years)
Over the longer term, the decline in prices due to biosimilar competition is expected to be similar to historical biologic precedents, with reductions reaching 30-50% below initial list prices. The lifecycle of the drug will also influence dynamic pricing; phase incentives, expanded indications, and label extensions could allow for sustained premium pricing in specific niches.
3. Key Influencing Factors
- Patent and exclusivity protections: Extended patent life or data exclusivity sustains premium pricing.
- Market penetration and volume growth: Increased adoption rates elevate revenues, offsetting unit price reductions.
- Regulatory shifts: New approvals, expanded indications, or regulatory changes can alter dynamic pricing models.
- Cost and reimbursement policies: Reimbursement adjustments and value assessment frameworks (e.g., ICER reports) influence net pricing.
Strategic Market Opportunities
- Biosimilar development and competition management: Proactively engaging in biosimilar partnerships or licensing agreements can mitigate price erosion.
- Indication expansion: Securing approvals for additional indications can extend market opportunity and justify higher prices.
- Patient access programs: Implementation of copay assistance and patient support initiatives can enhance adherence and increase market share.
- Global expansion: Entry into emerging markets may offer growth opportunities despite lower price points, diversifying revenue streams.
Risks and Uncertainties
- Regulatory hurdles: Delays or denials in approval processes impact market entry timing.
- Market competition: Rapid biosimilar launches can suppress prices.
- Healthcare policy changes: Shifts toward cost containment and stricter reimbursement policies may adversely affect profitability.
- Patent challenges: Litigation or patent expiry alters competitive landscape and pricing trajectories.
Key Takeaways
- NDC 60687-0846 operates within a high-growth, biologics-focused therapeutic area with significant demand potential.
- The current market favors premium pricing supported by patent protection, but biosimilar threats are imminent, necessitating strategic planning.
- Short-term prices are expected to remain stable or marginally increase; long-term prices likely to decline significantly due to biosimilar entry and cost-containment policies.
- Expanding indications, fostering partnerships with biosimilar manufacturers, and maintaining regulatory momentum are critical for optimizing market positioning.
- Continuous monitoring of competitive developments, regulatory timelines, and payer policies is essential for accurate pricing strategy and revenue optimization.
FAQs
Q1: How does patent protection affect the price of NDC 60687-0846?
A: Patent protection allows the manufacturer to maintain exclusivity, enabling premium pricing and market control. Once patents expire, biosimilars can enter the market, typically resulting in significant price reductions.
Q2: What factors are most likely to influence the price decline of biologics like NDC 60687-0846?
A: The launch of biosimilars, regulatory decisions regarding additional indications, payer negotiations, and policy changes focusing on cost containment are primary drivers influencing price decline.
Q3: How can manufacturers extend the commercial lifecycle of NDC 60687-0846?
A: Expanding indications, developing differentiated formulations, improving delivery methods, and securing regulatory exclusivities can prolong market relevance.
Q4: What is the projected impact of biosimilar competition on the drug’s pricing over the next decade?
A: Biosimilar competition is expected to lower prices by 30-50%, depending on market dynamics, with early biosimilar entries causing sharper declines.
Q5: How do regulatory decisions influence price projections?
A: Approval of additional indications or dosing options enhances market utility and can justify higher prices; conversely, delays or denials may restrict market potential, exerting downward pressure.
References
[1] Grand View Research. Biologics Market Size & Trends, 2022-2027.
[2] FDA Approvals and Patent Data, 2022.
[3] IQVIA. Biologics and Biosimilars Market Reports, 2022.
[4] ICER. Value-Based Pricing and Reimbursement Strategies, 2022.
[5] Healthcare Policy and Cost Containment Trends, 2022-2023.
Note: The analysis provided is based on current market data and trends, with inherent uncertainties typical of pharmaceutical commercial landscapes. Regular updates and detailed product-specific data should inform ongoing strategic decisions.
More… ↓
